News
The Gender Equality Fund Project commenced operations in Lagos State on July 4, 2025 with a Joint Inception Meeting that ...
Gilead will supply lenacapavir to Global Fund countries for HIV prevention, but questions remain amid PEPFAR cuts and funding ...
Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between with United ...
A five-item tool using spirometry and basic clinical data may predict recurrent tuberculosis with moderate accuracy, helping ...
Federal Minister for National Health Services, Regulations and Coordination, Syed Mustafa Kamal on Wednesday emphasized that ...
Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...
The drugmaker will provide, at no profit, doses to treat up to 2 million people in resource-limited countries. Meanwhile, Arvinas' John Houston is retiring from his role leading the biotech.
5h
Stocktwits on MSNGilead, Global Fund Enter Agreement To Supply HIV Prevention Drug To Low & Lower-Middle-Income CountriesGilead Sciences, Inc. (GILD) on Wednesday announced a strategic partnership agreement with the Global Fund to combat AIDS, ...
Humans have been getting infected by ancient bacteria and viruses for at least 37,000 years. Now, for the first time, ...
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalised plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results